Cloned (Comment) | Organism |
---|---|
CES2, recombinant expression of His10-tagged wild-type and mutant enzymes in HEK-293T cells, the enzyme is secreted to the cell medium | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | site-directed mutagenesis is used to replace the asparagine residues in the Asn-X-Ser/Thr sequons, by glutamine thus precluding binding of the sugar moieties to those putative sites. Each or the two potential N-glycosylation sites are mutated resulting in three mutated forms of the protein which lack either the first (p.Asn175Gln,Glyco1), the second (p. Asn340Gln, Glyco2) or both (p.Asn175Gln/Asn340Gln,Glyco1+2) glycosylation sites | Homo sapiens |
N175Q | site-directed mutagenesis, the mutant lacks the first glycosylation site, the mutation reduces the catalytic activity (by 43%) and the thermostability of the enzyme compared to wild-type | Homo sapiens |
N175Q/N340Q | site-directed mutagenesis, the mutant lacks both the glycosylation sites, the mutation reduces the catalytic activity (by 75%) and the thermostability of the enzyme compared to wild-type | Homo sapiens |
N340Q | site-directed mutagenesis, the mutant lacks the second glycosylation site, the mutation reduces the catalytic activity (by 39%) and the thermostability of the enzyme compared to wild-type | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | tunicamycin leads to decreased levels of secreted hCES2, but the enzyme is still active | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
extracellular | the enzyme is secreted. Tunicamycin leads to decreased levels of secreted hCES2, but the enzyme is still active. Mutation of each and both N-glycosylation sites leads to decreased levels of secreted active hCES2 | Homo sapiens | - |
- |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O00748 | - |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
glycoprotein | N-glycosylation of hCES2 is relevant for thermostability of the enzyme and also for its in vivo folding or secretion, but is not crucial for enzyme activity. Carboxylesterase 2 (hCES2) is a glycoprotein. Partial or non-glycosylated forms of a secreted form of hCES2 are obtained by three approaches: (i) enzymatic deglycosylation with peptide N-glycosidase F, (ii) incubation with the inhibitor tunicamycin, (iii) site-directed mutagenesis of each or both N-glycosylation sites. Deglycosylated protein does not show a detectable decrease in enzyme activity. The glycans are involved, to some extent, in protein folding in vivo, but removal of glycans does not abrogate the activity of secreted hCES2. Deglycosylation of purified recombinant His10-tagged hCES2 shows a decreased level of detection using the glycoprotein detection method with the deglycosylated bands only being faintly detected probably due to nonspecific binding or to O-glycosylation | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
carboxylesterase 2 | - |
Homo sapiens |
CES2 | - |
Homo sapiens |
HCE2 | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
evolution | carboxylesterases (CES) are a subset of esterases that belong to the alpha/beta hydrolase family | Homo sapiens |
malfunction | mutation of each and both N-glycosylation sites leads to decreased levels of secreted active hCES2. The thermostability of the glycosylation mutants is decreased | Homo sapiens |